Story perspectives
Obesity Rates Drop as GLP-1 Drug Use Soars
10/31/2025
44 6
1 of 1
Story summary
- A Gallup report shows the adult obesity rate fell to 37% in 2025 from nearly 40% in 2022.
- Glucagon-like peptide-1 (GLP-1) weight loss drugs use more than doubled since early 2024, now at 12.4%.
- The most notable improvements occurred among adults aged 40 to 64.
- Diabetes rate reached a record high of nearly 14%.
- Experts caution weight loss drugs should not replace healthy lifestyle changes, given self-reported data.
